 | |||||||||
 |  |  |  | ||||||
Calgary, Alberta – October 20, 2025 – TheNewswire – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE: NDAT) (OTCQB: NDATF) is pleased to announce the completion of the genetic swab and Questionnaire collection for two WHL-league teams of the three teams participating in the Epitome predictive analytics project. The third team is from the Ontario University Athletics (OUA) conference and its data collection is to begin before October 31 with closure expected prior to the end of November. The Corporation’s President, Jim Durward, states: “Player participation has been exceptional. It’s such a pleasure to work with people who understand the technology’s potential and want to apply it to inform better performance from individual players and entire teams.”
Regarding the previously announced RTO, the Corporation has been informed that the RTO target audit is ongoing and that the extended time frame is due largely to the large number of product SKUs and the tracking from purchase to sale of these items. The Corporation has also been informed that the tax opinion that the controlling shareholder of the RTO target was waiting for, has been received and that the associated paperwork and RTO share structure are now being finalized in advance of the anticipated private placement and presentation to the CSE. Trading in the Corporation’s shares will remain halted until the RTO is completed or abandoned.
For Further Information, please contact:
Jim Durward, President, CEO/CTO
Email: jimd@ndatalyze.com
nDatalyze Website: https://www.ndatalyze.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Copyright (c) 2025 TheNewswire - All rights reserved.
